APA (7th ed.) Citation

IP, S., MVG, L., VS, P., AF, P. M., AL, R. R., AA, C., . . . M, C. (2020). Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study). PloS one, 15(6), e0235381. https://doi.org/10.1371/journal.pone.0235381

Chicago Style (17th ed.) Citation

IP, Safe, et al. "Safety and Efficacy of N-acetylcysteine in Hospitalized Patients with HIV-associated Tuberculosis: An Open-label, Randomized, Phase II Trial (RIPENACTB Study)." PloS One 15, no. 6 (2020): e0235381. https://doi.org/10.1371/journal.pone.0235381.

MLA (9th ed.) Citation

IP, Safe, et al. "Safety and Efficacy of N-acetylcysteine in Hospitalized Patients with HIV-associated Tuberculosis: An Open-label, Randomized, Phase II Trial (RIPENACTB Study)." PloS One, vol. 15, no. 6, 2020, p. e0235381, https://doi.org/10.1371/journal.pone.0235381.